Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An experimental
drug , so far shown to reducetumour growth ,metastasis , andangiogenesis .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word cabozantinib.
Examples
-
The company plans to launch a late-stage study of cabozantinib in prostate cancer in the second half of this year.
Bayer Drug Shows Promise in Treating Prostate Cancer Ron Winslow 2011
-
And on Monday, Exelixis Inc. reported promising results from a midstage, or Phase II, study of its drug cabozantinib, in advanced prostate cancer.
Bayer Drug Shows Promise in Treating Prostate Cancer Ron Winslow 2011
-
The company plans to launch a late-stage study of cabozantinib in prostate cancer in the second half of this year.
Bayer Drug Shows Promise in Treating Prostate Cancer Ron Winslow 2011
-
Bloomberg reports that the company anticipates takeover offers following positive results in a study of its experimental prostate cancer treatment, cabozantinib, and that some large pharmaceutical companies have shown interest, citing an unnamed person with knowledge of the matter.
-
And on Monday, Exelixis Inc. reported promising results from a midstage, or Phase II, study of its drug cabozantinib, in advanced prostate cancer.
Bayer Drug Shows Promise in Treating Prostate Cancer Ron Winslow 2011
-
Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients.
unknown title 2011
-
Exelixis believes cabozantinib has the potential to be a high-quality, differentiated pharmaceutical product that can make a meaningful difference in the lives of patients.
unknown title 2011
-
During the presentation, Dr. Schwab will review the most recent publicly available data for cabozantinib in castration-resistant prostate cancer CRPC and discuss the pivotal trial plans and regulatory strategy for the compound in CRPC.
unknown title 2011
-
Exelixis is focusing its resources and development efforts exclusively on cabozantinib, its most advanced solely-owned product candidate, in order to maximize the therapeutic and commercial potential of this compound.
unknown title 2011
-
During each presentation, Dr. Morrissey will provide a general business update, review the most recent publicly available data for cabozantinib in castration-resistant prostate cancer, and discuss the pivotal trial plans and regulatory strategy for the compound.
unknown title 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.